World-Class Leadership

BioSig is led by a team of experienced professionals and experts and overseen by a board of directors with decades of experience working with both blue-chip brands and start-ups. Together, this team brings a distinctive skill set to managing and growing the company.

Management Team

Kenneth L. Londoner, MBA

Founder, Chief Executive Officer, Chairman, and Director

Kenneth L. Londoner, MBA

Kenneth L. Londoner, MBA

Founder, Chief Executive Officer, Chairman, and Director

Mr. Londoner is a capital markets and capital architecture expert and a senior life science executive. Having started his career as a research analyst for J. & W. Seligman & Co., Inc., a leading institutional money management firm in New York City, NY, he quickly found himself at the forefront of the biotech industry in the early 1990s, leading him to manage $3.5 billion in mutual and pension funds and international assets.

His passion for medical innovation led him to co-found, govern and bring to the public market several life science companies, including BioSig Technologies, Inc. [NASDAQ: BSGM]. Working in close collaboration with key opinion leaders in electrophysiology, BioSig aims to improve the outcomes of cardiac ablations for the treatment of arrhythmias through novel technological solutions developed by the company and further apply its core competency in advanced biomedical signal processing and analysis to other areas of medicine.

His prior experience in recognizing the early potential of biotech led Londoner to for the Alliance for Advancing Bioelectronic Medicine, an independent non-profit network of professionals dedicated to innovation at the intersection of healthcare and technology. The Alliance aims to increase awareness of bioelectronic medicine and build a platform for collaboration among stakeholders. Over the last decade, Londoner formed top-level relationships with several medical centers of excellence such as Mayo Clinic, NYU Langone Hospital, and UCLA, as well as other stakeholders, including investment communities, intellectual property experts, and supply chain partners.

Mr. Londoner earned his BA in Economics from Lafayette College in 1989, and his Master of Business Administration in Management and Finance from New York University in 1994. Between 1999-2002, he served as an adjunct professor at the Columbia Business School. Additionally, in 2015, Mr. Londoner founded the Immersive Internship Program at Lafayette College.

Frederick D. Hrkac

Executive Vice President

Frederick D. Hrkac

Frederick D. Hrkac

Executive Vice President

Mr. Hrkac has served as our director from April 2022 to February 2024. Mr. Hrkac has more than 30 years of experience in the medical device industry as an executive and corporate board director. He is currently serves on the board of Serres in Helsinki, Finland since September 2018, and Spineart in Geneva, Switzerland as chairman of the board since August 2017. In 2017, he served as senior vice president corporate development and from 2014-2016 served a senior vice president of global commercial operations of Biosensors International. From 2009-2011, Mr. Hrkac served as Europe, Middle East & Africa president of Boston Scientific where he was responsible for close to $2 billion of sales. From 2005-2009, Mr. Hrkac was an executive of Sorin Group CRM, Paris, France. And, from November 1990-April 2005 he lived in 6 different countries working as an executive for Johnson & Johnson including Biosense Webster, a Johnson & Johnson company having laid the groundwork strategically for the most successful J&J division of the last 20 years with sales growing from a few hundred million dollars to several billion dollars.  Mr. Hrkac holds an Honors Bachelor of Business Administration from the Wilfrid Laurier University, Waterloo, Ontario Canada and currently resides in Zagreb, Croatia. Mr. Hrkac brings extensive expertise in global marketing and strategic business development, making him a valuable resource for our Board.

Andrew Ballou

Vice President, Investor Relations

Andrew Ballou

Andrew Ballou

Vice President, Investor Relations

Mr. Ballou brings to BioSig over 25 years of experience in capital markets, including institutional equity sales and research analysis. Most recently, Mr. Ballou served as Managing Director, Head of Institutional Equity Sales at Janney Montgomery Scott LLC., a role in which he oversaw key accounts, including large multi-manager hedge funds, mutual funds and dedicated sector funds. Prior to that role Mr. Ballou managed selected key account coverage at RBC Capital Markets, including Millennium Partners, Soros Fund Management, SIR Capital, Columbia Threadneedle, Two Sigma Investments and Times Square Capital Management. During the course of his career Mr. Ballou analyzed various private and public companies in healthcare, media and retail sectors. Mr. Ballou graduated from Hampden-Sydney College, Virginia, with a Bachelor of Arts in English.

Zachary Koch, CCDS, CEPS

Principal Advisor, Product Development

Zachary Koch, CCDS, CEPS

Zachary Koch, CCDS, CEPS

Principal Advisor, Product Development

Zachary Koch brings over 20 years of experience in clinical strategy and sales in electrophysiology and cardiovascular devices. Mr. Koch joins BioSig’s leadership following a 16-year tenure at Abbott and St. Jude Medical, where he held numerous positions across the company’s clinical, sales, training, and commercial teams. Mr. Koch has personally supported over 5000 cardiac mapping procedures, and has created and lead several advanced training and education initiatives for St Jude Medical and Abbott EP. More recently, within his role as Manager of Strategic EP Clinical Development, Mr. Koch successfully founded and launched the Key Accounts Organization for Abbott EP and led the business and clinical strategy across nine National Key Accounts. These efforts generated a 20% increase in EP case volume and revenue for the company. He also founded the AAA advanced training program that led to a significant improvement of clinical support with the Key Accounts Organization.  He has been recognized for his sales and business delivery as a three-time recipient of Abbott’s Field Service Award, an honor bestowed upon the top clinical specialists in the US sales division.  He is also a certified electrophysiology and cardiac device specialist, a distinguished honor apportioned by the International Board of Heart Rhythm Examiners. 

Mr. Koch served as a Hospital Corpsman in the United States Navy.  He provided infantry medical support for the Second Marine Division and the Executive Medical Team at the National Naval Medical Center in Washington DC. He holds a degree in Cardiovascular Technology from the Naval School of Health Sciences, where he graduated with honors and distinction.

Advisory Board

Sim Farar

Sim Farar

Advisor

Mr. Farar brings to Biosig over 30 years of experience in both public and private sectors. Most recently, Mr. Farar was nominated by President J. Biden to serve as one of four United States representatives for the 76th Session General Assembly of the United Nations. This nomination follows his appointment as United States Representative to the 54th General Assembly from 1999-2000.  Remarkably, this is only the second time in history for someone to be appointed twice.

In 2002, Los Angeles Mayor James Hahn appointed Mr. Farar to serve as a commissioner for the $12 billion Los Angeles Fire and Police Pension’s Trustee Fund. In 2001, he was appointed to the Woodrow Wilson Council, the private sector advisory board of the Woodrow Wilson International Center for Scholars in Washington, DC. In 1999, he was appointed by President Clinton and confirmed by the U.S. Senate to serve as the United States Representative to the 54th General Assembly at the United Nations in New York City. In 1994, Mr. Farar received a Presidential appointment to the Advisory Committee on the Arts of the John F. Kennedy Center for Performing Arts in Washington, DC.

In the private sector, Mr. Farar has served as CEO, Chairman of the Board, Director, and consultant to a number of companies, including JDF Investment CO. LLC, IFC Financial Services Corp, and has served as an adviser to several other private and public companies.

Lorraine Spurge

Lorraine Spurge

Advisor

As founder and CEO of Maple Stone Capital Advisors, Ms. Spurge began her 40-year financial career with Drexel Burnham Lambert and became one of the most successful women on Wall Street. She managed the capital markets group for Drexel Burnham Lambert in the 1980s. At Drexel, she helped raise more than $200 billion for middle market growth companies. For the next two decades, she was an entrepreneur and CEO of International Capital Access, Knowledge Exchange and Spurge Ink!

As a motivational speaker, Ms. Spurge has been a contributor to radio and TV stations including CNN, CNBC, and KCBS, and authored several books including Portraits of the American Dream, MCI: Failure is not an Option, and Money Clips. She currently serves on the boards of EEM, Involvy, Nupulse, and Working Nation, and is a mentor for Women in America. She is an emeritus board member of the Prostate Cancer Foundation and has served on the Board of the Geffen Playhouse as well as the Board of Advisors for George Washington University.

Edwin Wang

Edwin Wang

Advisor

Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC (2007), a pioneering direct secondary and co-investment sponsor in middle market private equity that successfully harvested a substantial co-investment in $660M Evercore Capital Partners II LP and $1.5B in separate accounts. From 2002 to 2007 while at predecessor affiliate Asymmetry Capital LLC, he led the successful financial restructuring and liquidation of $1B in venture capital portfolios from Zero Stage Capital whose legacy spawned a forerunner to Moderna. These accomplishments were chronicled in two Harvard Business School case studies and other publications, including The Deal Magazine. Previously, during an eight-year investment banking career he led Greater China cross-border direct investment at Credit Suisse and spearheaded a technology investment JV with Taipei-based China Development Bank culminating in $250M Asia Corporate Partners Fund whose investments comprised Texas Instruments/Acer, United Microelectronics and Taiwan Semiconductor Manufacturing.

Mr. Wang holds a B.A. in Economics from Columbia University and a Visiting Fellowship in Finance at the MIT Sloan School of Management under the tutelage of the late Nobel laureate, Dr. Franco Modigliani.

Dr. Ramachandra Malya, M.D.

Dr. Ramachandra Malya, M.D.

Advisor

Dr. Malya brings to BioSig over 40 years of experience in the medical field. His strong business acumen has allowed Dr. Malya to serve as Founding Board Member of several successful healthcare entities and two Texas savings banks with valuations in excess of one billion dollars. Throughout his career, Dr. Malya raised capital for a number of promising healthcare start-ups and managed an important family office funds with extensive medical relationships. Dr. Malya is a Diplomate of American Board of Internal Medicine and American College of Managed Care Medicine.

Frank J. Quintero

Frank J. Quintero

Advisor

Mr. Quintero is a Principal at The Yucaipa Companies, a premier investment firm founded by Ron Burkle in 1986. His responsibilities as a Principal of the firm encompass deal origination, negotiating transactions, investor relations and corporate communications. Working closely with The Yucaipa Companies' founder, Mr. Quintero actively participated in multiple phases of the investment process since joining the firm. The Yucaipa Companies has completed mergers and acquisitions valued at more than $35 billion.

Prior to joining The Yucaipa Companies, Mr. Quintero served as Special Assistant to California Governor Gray Davis. In this position he served as a liaison to labor officials and business groups; as well as local, state, and national elected officials. Mr. Quintero was also an advisor to Governor Davis on over 300 boards and commission appointments within the California state government. Under Governor Davis' leadership the Appointments Unit placed more women and people of color in appointed positions than any of California's previous governors.  

Active in numerous statewide and local political campaigns, in 1998 Mr. Quintero worked as State Field Director for the California Democratic Party Coordinated Campaign. As part of the three-person team managing a budget of several million dollars, Mr. Quintero directed over thirty offices throughout the state and oversaw print, radio, and direct mail advertising. His efforts on behalf of the Coordinated Campaign's “Get-Out-The-Vote” drive produced record voter registration and turnout in low-income communities.

Based on his experience unifying divergent groups, Mr. Quintero was chosen as one of 60 Americans to receive a Marshall Fellowship in 2001. He became part of a team of scholars and government officials brought together to advise European Union member nations, NGOs, and the head of NATO on economic integration and immigration policy.

Zachariah P. Zachariah, M.D.

Zachariah P. Zachariah, M.D.

Advisor

Previously, Dr. Zachariah served on the Florida Board of Governors of the State University system from 2003 to 2010 and from 2017 to May 2019. He has been practicing interventional cardiology at Holy Cross Hospital since 1976 and as its Director of Cardiovascular Services until 2010. He has also served on the National Heart, Lung and Blood Institute at the National Institutes of Health from 1990 to 1993 and as a member of the U.S. delegation to the World Health Organization in Geneva, Switzerland. He also served as Chairman of the Florida Board of Medicine from 1990-1992, 2000-2001 and 2013-2014. He also served as a member of the President’s Advisory Commission on Asian Americans and Pacific Islanders appointed by President George W. Bush in 2001.

Dr. Zachariah is board-certified in internal medicine and cardiology and specializes in cardiology, cardiac catheterization, and interventional cardiology and has performed more than 30,000 heart catheterizations and interventional procedures in Broward County. He co-authored several scientific papers, and participated in various clinical trials.

He received his medical degree from the Armed Forces Medical College in India, and then completed his residency at St. Joseph’s Hospital and Medical Center in Paterson, New Jersey. He also completed a fellowship in interventional cardiology at the Cleveland Clinic Educational Foundation in Cleveland, Ohio.

Dr. Zachariah is a holder of numerous awards, including the Ellis Island American Legend Award, the Golden Heart Award from the American Heart Association, Freedom Foundation Medal of Honor from the Freedom Foundation at Valley Forge, and Ellis Island Medal of Honor.

Anthony Amato

Anthony Amato

Advisor

Mr. Amato brings over twenty years of corporate executive leadership and entrepreneurial expertise in the medical industry to BioSig’s advisory board. He founded Amega Scientific Corporation in 1999 and grew the company from a start-up operation to a worldwide multi-million dollar industry leader. After the sale of Amega Scientific, Amato served as director of sales for Mesa Labs in Denver, CO, a Nasdaq listed corporation (Nasdaq: MLAB), where he specialized in providing quality control products to ensure safety and efficacy for in-hospital medical devices.

As a natural-born entrepreneurial thinker and business leader, in 2017, Amato founded InQuest Science, which focuses on troubleshooting product defect issues and providing advanced medical device training. Mr. Amato has hands-on executive skills at engaging and influencing key stakeholders to grow business and optimize profits.

Board of Directors

Frederick D. Hrkac

Executive Vice President

Frederick D. Hrkac

Frederick D. Hrkac

Executive Vice President

Mr. Hrkac has served as our director from April 2022 to February 2024. Mr. Hrkac has more than 30 years of experience in the medical device industry as an executive and corporate board director. He is currently serves on the board of Serres in Helsinki, Finland since September 2018, and Spineart in Geneva, Switzerland as chairman of the board since August 2017. In 2017, he served as senior vice president corporate development and from 2014-2016 served a senior vice president of global commercial operations of Biosensors International. From 2009-2011, Mr. Hrkac served as Europe, Middle East & Africa president of Boston Scientific where he was responsible for close to $2 billion of sales. From 2005-2009, Mr. Hrkac was an executive of Sorin Group CRM, Paris, France. And, from November 1990-April 2005 he lived in 6 different countries working as an executive for Johnson & Johnson including Biosense Webster, a Johnson & Johnson company having laid the groundwork strategically for the most successful J&J division of the last 20 years with sales growing from a few hundred million dollars to several billion dollars.  Mr. Hrkac holds an Honors Bachelor of Business Administration from the Wilfrid Laurier University, Waterloo, Ontario Canada and currently resides in Zagreb, Croatia. Mr. Hrkac brings extensive expertise in global marketing and strategic business development, making him a valuable resource for our Board.